$TMGI
Marquie Group, Inc.

2023 Q1 Form 10-Q Financial Statement

#000168316823000273 Filed on January 23, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022 Q2
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $69.47K $183.1K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $230.00 $780.00
YoY Change
% of Gross Profit
Operating Expenses $69.47K $88.69K
YoY Change -3.82% 17.02%
Operating Profit -$69.47K -$88.69K
YoY Change -3.82% 17.02%
Interest Expense $102.5K $79.92K
YoY Change -16.93% -51.64%
% of Operating Profit
Other Income/Expense, Net -$603.8K -$79.92K
YoY Change 13.3% -105.04%
Pretax Income -$673.3K $1.634M
YoY Change 11.26%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$673.3K -$168.6K
YoY Change 11.26% -111.16%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 756.6M shares 16.19M shares
Diluted Shares Outstanding 756.6M shares 292.9M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $50.00 $780.00
YoY Change
Cash & Equivalents $45.00 $784.00 $353.00
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.159K $1.389K $4.309K
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $45.00 $784.00 $353.00
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $1.160K $1.390K
YoY Change
Goodwill
YoY Change
Intangibles $10.37K $10.37K $10.37K
YoY Change
Long-Term Investments $6.200M $6.200M
YoY Change
Other Assets $6.235M $6.221M $12.53K
YoY Change
Total Long-Term Assets $6.235M $6.221M $12.53K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $45.00 $784.00 $353.00
Total Long-Term Assets $6.235M $6.221M $12.53K
Total Assets $6.235M $6.222M $12.89K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $69.41K $71.32K $35.41K
YoY Change
Accrued Expenses $1.575M $1.435M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $3.512M $3.470M
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.693M $7.809M $5.668M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $6.693M $7.809M $5.668M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $6.693M $7.809M $5.668M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$15.03M -$16.16M -$15.88M
YoY Change
Common Stock $75.66K $75.66K $1.621K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$458.2K -$1.587M -$5.655M
YoY Change
Total Liabilities & Shareholders Equity $6.235M $6.222M $12.89K
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022 Q2
OPERATING ACTIVITIES
Net Income -$673.3K -$168.6K
YoY Change 11.26% -111.16%
Depreciation, Depletion And Amortization $230.00 $780.00
YoY Change
Cash From Operating Activities -$11.54K -$47.66K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$14.00K -$9.250K
YoY Change
Cash From Investing Activities -$14.00K -$9.250K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 24.80K 57.34K
YoY Change
NET CHANGE
Cash From Operating Activities -11.54K -47.66K
Cash From Investing Activities -14.00K -9.250K
Cash From Financing Activities 24.80K 57.34K
Net Change In Cash -740.0 430.0
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$11.54K -$47.66K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001434601
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--05-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
TMGI Default Interest Added To Notes Principal Balance
DefaultInterestAddedToNotesPrincipalBalance
usd
CY2022Q4 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
usd
CY2022Q2 us-gaap Long Term Notes And Loans
LongTermNotesAndLoans
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-54163
dei Entity Registrant Name
EntityRegistrantName
The Marquie Group, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
FL
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2091212
dei Entity Address Address Line1
EntityAddressAddressLine1
7901 4th ST N
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 4000
dei Entity Address City Or Town
EntityAddressCityOrTown
St. Petersburg
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
33702
dei City Area Code
CityAreaCode
800
dei Local Phone Number
LocalPhoneNumber
351-3021
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
756612000 shares
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
784 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
353 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
784 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
353 usd
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
6200000 usd
CY2022Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
0 usd
CY2022Q4 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
9247 usd
CY2022Q2 us-gaap Loans And Leases Receivable Related Parties
LoansAndLeasesReceivableRelatedParties
0 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20259 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19481 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1389 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2167 usd
CY2022Q4 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2022Q2 us-gaap Indefinite Lived Trademarks
IndefiniteLivedTrademarks
10365 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
6221001 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12532 usd
CY2022Q4 us-gaap Assets
Assets
6221785 usd
CY2022Q2 us-gaap Assets
Assets
12885 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
71318 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
35405 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
397989 usd
CY2022Q2 us-gaap Interest Payable Current
InterestPayableCurrent
334180 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1036917 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
30890 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
6889 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1414542 usd
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1419108 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
2073451 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
135551 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2814786 usd
CY2022Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2817101 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7809003 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5667562 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7809003 usd
CY2022Q2 us-gaap Liabilities
Liabilities
5667562 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
200 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
200 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
756612000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
756612000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16189732 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16189732 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
75663 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1621 usd
CY2022Q4 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2022Q2 TMGI Common Stock Payable
CommonStockPayable
8460 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
14486896 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
10213431 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16158237 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15878189 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1587218 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6221785 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12885 usd
CY2022Q4 us-gaap Revenues
Revenues
0 usd
CY2021Q4 us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
us-gaap Revenues
Revenues
0 usd
CY2022Q4 us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2021Q4 us-gaap Salaries And Wages
SalariesAndWages
30000 usd
us-gaap Salaries And Wages
SalariesAndWages
120000 usd
us-gaap Salaries And Wages
SalariesAndWages
60000 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
17992 usd
CY2021Q4 us-gaap Professional Fees
ProfessionalFees
40885 usd
us-gaap Professional Fees
ProfessionalFees
56113 usd
us-gaap Professional Fees
ProfessionalFees
40885 usd
CY2022Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
10696 usd
CY2021Q4 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
4905 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
12001 usd
us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
9066 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
88688 usd
CY2021Q4 us-gaap Operating Expenses
OperatingExpenses
75790 usd
us-gaap Operating Expenses
OperatingExpenses
188114 usd
us-gaap Operating Expenses
OperatingExpenses
109951 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-88688 usd
CY2021Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-75790 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-188114 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-109951 usd
CY2022Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
0 usd
CY2021Q4 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
2827992 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41194 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1556558 usd
CY2022Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14878 usd
CY2021Q4 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
112987 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14878 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
213361 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
79920 usd
CY2021Q4 us-gaap Interest Expense
InterestExpense
165263 usd
us-gaap Interest Expense
InterestExpense
133128 usd
us-gaap Interest Expense
InterestExpense
408524 usd
CY2022Q4 TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
0 usd
CY2021Q4 TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-1075907 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
0 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-2529399 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-79920 usd
CY2021Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1586822 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-91934 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1381365 usd
CY2022Q4 us-gaap Profit Loss
ProfitLoss
-168608 usd
CY2021Q4 us-gaap Profit Loss
ProfitLoss
1511032 usd
us-gaap Profit Loss
ProfitLoss
-280048 usd
us-gaap Profit Loss
ProfitLoss
-1491316 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-168608 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
1511032 usd
us-gaap Net Income Loss
NetIncomeLoss
-280048 usd
us-gaap Net Income Loss
NetIncomeLoss
-1491316 usd
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2021Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
CY2021Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.20
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
292900441 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
292900441 shares
CY2021Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
8700950 shares
CY2021Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
8700950 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
301040848 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
301040848 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7447032 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
7447032 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-5654677 usd
CY2022Q3 TMGI Stock Issued During Period Shares Reverse Stock Splits Value
StockIssuedDuringPeriodSharesReverseStockSplitsValue
0 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-111440 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-5766117 usd
CY2022Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
147507 usd
CY2022Q4 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4200000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-168608 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-1587218 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-4766118 usd
CY2021Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1503100 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-3002348 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
-6265366 usd
CY2021Q4 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1121796 usd
CY2021Q4 us-gaap Net Income Loss
NetIncomeLoss
1511032 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-3632539 usd
us-gaap Net Income Loss
NetIncomeLoss
-280048 usd
us-gaap Net Income Loss
NetIncomeLoss
-1491316 usd
us-gaap Depreciation
Depreciation
778 usd
us-gaap Depreciation
Depreciation
1364 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
41194 usd
us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1556558 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
14878 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
213361 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-0 usd
TMGI Income Loss On Conversion Of Notes Payable And Accrued Interest
IncomeLossOnConversionOfNotesPayableAndAccruedInterest
-2529399 usd
TMGI Default Interest Added To Notes Principal Balance
DefaultInterestAddedToNotesPrincipalBalance
102400 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
35913 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
8353 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
111316 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
87666 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
110700 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
55000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47657 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-50331 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
9247 usd
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
-0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9247 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
0 usd
us-gaap Proceeds From Repayments Of Bank Overdrafts
ProceedsFromRepaymentsOfBankOverdrafts
-397 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
69435 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
45000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
500 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
12100 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
25272 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
31500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
57335 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
50331 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
431 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
0 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
353 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
784 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
6200000 usd
TMGI Issuance Of Stock And Promissory Note For Investment In Acquisition
IssuanceOfStockAndPromissoryNoteForInvestmentInAcquisition
0 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
38880 usd
TMGI Initial Derivative Liability Charged To Debt Discounts
InitialDerivativeLiabilityChargedToDebtDiscounts
45000 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
147507 usd
TMGI Conversion Of Debt And Accrued Interest Into Common Stock
ConversionOfDebtAndAccruedInterestIntoCommonStock
95496 usd
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1414542 usd
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1419108 usd
CY2022Q4 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1414542 usd
CY2022Q2 us-gaap Notes And Loans Payable Current
NotesAndLoansPayableCurrent
1419108 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2022Q2 us-gaap Inventory Gross
InventoryGross
21648 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
20259 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
19481 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1389 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
2167 usd
us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
0 usd
us-gaap Depreciation
Depreciation
778 usd
us-gaap Depreciation
Depreciation
1364 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1036917 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2021Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
832967 usd
us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
120000 usd
TMGI Payments To Consultants
PaymentsToConsultants
9300 usd
CY2022 TMGI Payments To Consultants
PaymentsToConsultants
26750 usd
CY2022Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
1036917 usd
CY2022Q2 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
926217 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
1445432 usd
CY2022Q2 us-gaap Long Term Notes Payable
LongTermNotesPayable
1425997 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
30890 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
6889 usd
CY2022Q4 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1414542 usd
CY2022Q2 us-gaap Notes And Loans Payable
NotesAndLoansPayable
1419108 usd
CY2022Q4 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
2073451 usd
CY2022Q2 us-gaap Notes Payable Related Parties Current And Noncurrent
NotesPayableRelatedPartiesCurrentAndNoncurrent
135551 usd
CY2022Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
2073451 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
135551 usd
CY2022Q4 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 usd
CY2022Q2 us-gaap Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
0 usd
CY2022Q4 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
611862 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2814786 usd
CY2022Q2 us-gaap Derivative Liability Notional Amount
DerivativeLiabilityNotionalAmount
572982 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
2814786 usd
CY2022Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2817101 usd
CY2021 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
4304842 shares
CY2021 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
835050 usd
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-1445042 usd
CY2022Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,000 reverse split
CY2022Q4 TMGI Working Capital
WorkingCapital
-7808219 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-16158237 usd

Files In Submission

Name View Source Status
0001683168-23-000273-index-headers.html Edgar Link pending
0001683168-23-000273-index.html Edgar Link pending
0001683168-23-000273.txt Edgar Link pending
0001683168-23-000273-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
marquie_10q-ex3101.htm Edgar Link pending
marquie_10q-ex3201.htm Edgar Link pending
marquie_i10q-113022.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tmgi-20221130.xsd Edgar Link pending
tmgi-20221130_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
tmgi-20221130_def.xml Edgar Link unprocessable
tmgi-20221130_cal.xml Edgar Link unprocessable
marquie_i10q-113022_htm.xml Edgar Link completed
tmgi-20221130_lab.xml Edgar Link unprocessable